Unichem Laboratories has shared an important update regarding its Roha Active Pharmaceutical Ingredients (API) facility. Following the recent inspection conducted by the United States Food and Drug Administration (USFDA) from June 16 to June 20, 2025, the company has received the Establishment Inspection Report (EIR).
The USFDA has classified the inspection as Voluntary Action Initiated (VAI), reflecting a positive outcome for the facility. This classification indicates that the Roha API plant is compliant with USFDA regulations and that any observations noted during the inspection are minor and do not pose a significant risk to product quality or patient safety.
Unichem Laboratories continues to maintain high standards of manufacturing quality and regulatory compliance across all its facilities, reinforcing its commitment to providing safe and effective pharmaceutical products globally.
Following this news, Unichem Laboratories shares were up 7%, trading between a low of ₹508.15 and a high of ₹557.55. The stock opened at ₹510.00, with a previous close of ₹509.05. Its 52-week low and high stand at ₹483.00 and ₹937.95, respectively.
